Ectonucleotide pyrophosphatase 1 targeting therapeutic - InSilico Medicine
Alternative Names: ENPP1 inhibitor - Insilico MedicineLatest Information Update: 07 Sep 2023
At a glance
- Originator InSilico Medicine
- Class Antineoplastics; Small molecules
- Mechanism of Action Ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 13 Aug 2023 Preclinical trials in Solid tumours in USA (unspecified route) (InSilico Medicine Pipeline, August 2023)